Pathogenic T Cells in Celiac Disease Change Phenotype on Gluten Challenge: Implications for T‐Cell‐Directed Therapies

Mostrar otras versiones (1)

Gluten‐specific CD4(+) T cells being drivers of celiac disease (CeD) are obvious targets for immunotherapy. Little is known about how cell markers harnessed for T‐cell‐directed therapy can change with time and upon activation in CeD and other autoimmune conditions. In‐depth characterization of glute...

Descripción completa

Detalles Bibliográficos
Autores principales: Christophersen, Asbjørn, Zühlke, Stephanie, Lund, Eivind G., Snir, Omri, Dahal‐Koirala, Shiva, Risnes, Louise Fremgaard, Jahnsen, Jørgen, Lundin, Knut E. A., Sollid, Ludvig M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8564461/
https://www.ncbi.nlm.nih.gov/pubmed/34495570
http://dx.doi.org/10.1002/advs.202102778

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8564461/
https://www.ncbi.nlm.nih.gov/pubmed/34495570
http://dx.doi.org/10.1002/advs.202102778

Ejemplares similares